Coastal Bridge Advisors’s West Pharmaceutical WST Stock Holding History

Coastal Bridge Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,900	Closed	-$284K	–	145
2018 Q4	$284K	Hold	2,900	–	–	0.11%	93
2018 Q3	$358K	Hold	2,900	–	–	0.14%	86
2018 Q2	$288K	Hold	2,900	–	–	0.12%	97
2018 Q1	$256K	Hold	2,900	–	–	0.09%	103
2017 Q4	$289K	Hold	2,900	–	–	0.09%	92
2017 Q3	$279K	Hold	2,900	–	–	0.09%	86
2017 Q2	$274K	Buy	+2,900	New	+$267K	0.09%	79

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Coastal Bridge Advisors's WST Position: Q1 2019 in Review

Coastal Bridge Advisors sold out of West Pharmaceutical (WST) in Q1 2019, closing a stake of 2,900 shares — an estimated $284K sold.

Coastal Bridge Advisors first reported a position in WST in Q2 2017 and held it in 7 quarters. The position peaked at $358K in Q3 2018. 379 funds tracked by Wall St. Rank hold WST as of Q1 2019.

Coastal Bridge Advisors reported no remaining West Pharmaceutical position as of Q1 2019 after selling out during the quarter.
Coastal Bridge Advisors sold 2,900 West Pharmaceutical shares in Q1 2019, an estimated $284K.
Coastal Bridge Advisors first reported a position in West Pharmaceutical in Q2 2017 and held it in 7 quarters.
Coastal Bridge Advisors's West Pharmaceutical position peaked at $358K in Q3 2018.
379 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2019.

Based on Coastal Bridge Advisors's 13F filing for Q1 2019, filed 8 May 2019.